FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant Depression

The green light means ketamine–an anesthetic abused as a party drug but promoted by some doctors without FDA approval as a necessary treatment for the most severely depressed patients—has spawned the first materially new depression treatment in decades.

Read the full post on Forbes - Healthcare